Department of Clinical Chemistry, University of Oulu, Oulu, Finland.
Thyroid. 2012 Sep;22(9):944-50. doi: 10.1089/thy.2011.0377. Epub 2012 Aug 8.
Smokers in the general population have lower thyrotropin (TSH) and higher free triiodothyronine (fT3) and free thyroxine (fT4) concentrations, but the results in pregnant population vary from no effect to a decrease in TSH and fT4 concentrations and an increase in fT3 levels. Our objective was to further evaluate the question of whether there is an association between smoking, before and during pregnancy, with maternal thyroid function during pregnancy and with the risk for subsequent hypothyroidism.
Our study population was a prospective population-based cohort (N=9362), the Northern Finland Birth Cohort 1986, with extensive data throughout gestation. The mothers underwent serum sampling in early pregnancy. The samples were assayed for TSH, fT3, fT4, thyroid-peroxidase antibodies (TPO-Ab), and thyroglobulin antibodies (TG-Abs) (n=5805). Mothers with thyroid dysfunction diagnosed before or during pregnancy were excluded, leaving 4837 euthyroid mothers. The smoking status of mothers and fathers were requested by questionnaires during pregnancy. Subsequent maternal morbidity relating to hypothyroidism 20 years after the index pregnancy was evaluated using national registers.
Euthyroid mothers who smoked before, or continued smoking during first trimester of pregnancy, had higher serum fT3 (p<0.001) and lower fT4 (p=0.023) concentrations than nonsmokers. Smoking in the second trimester was associated with higher fT3 (p<0.001) concentrations, but no difference in fT4 concentrations compared with nonsmokers. TG-Abs were less common among smoking than nonsmoking mothers (2.5% vs. 4.7%, p<0.001), but the prevalence of TPO-Ab was similar. Paternal smoking had no independent effect on maternal early pregnancy thyroid hormone or antibody concentrations. The risk of subsequent maternal hypothyroidism after follow-up of 20 years was similar among prepregnancy smokers and nonsmokers.
In euthyroid women, smoking during pregnancy was associated with higher fT3 levels and lower fT4 levels; possibly reflecting smoking-induced changes in peripheral metabolism of thyroid hormones. No differences were found in TSH concentrations between smokers and nonsmokers. Our results differ from those of the general population, which usually have shown smoking-induced thyroidal stimulation. This is possibly due to pregnancy-induced changes in thyroid function. Decreases in fT4 levels among smokers might predispose to hypothyroidism or hypothyroxinemia during pregnancy. Despite these changes in thyroid function, smoking did not increase the woman's risk of subsequent hypothyroidism.
一般人群中的吸烟者甲状腺刺激素(TSH)水平较低,游离三碘甲状腺原氨酸(fT3)和游离甲状腺素(fT4)水平较高,但孕妇人群的结果则从 TSH 和 fT4 浓度无变化到降低,fT3 水平升高。我们的目的是进一步评估在怀孕前和怀孕期间吸烟与孕妇妊娠期间的甲状腺功能以及随后发生甲状腺功能减退症的风险之间是否存在关联。
我们的研究人群是一个前瞻性的基于人群的队列(N=9362),即 1986 年芬兰北部出生队列,整个孕期都有广泛的数据。母亲在孕早期进行血清采样。对样本进行 TSH、fT3、fT4、甲状腺过氧化物酶抗体(TPO-Ab)和甲状腺球蛋白抗体(TG-Ab)的检测(n=5805)。排除在怀孕前或怀孕期间诊断为甲状腺功能障碍的母亲,留下 4837 名甲状腺功能正常的母亲。在怀孕期间通过问卷调查了解母亲和父亲的吸烟状况。使用国家登记册评估指数妊娠 20 年后与甲状腺功能减退症相关的母亲后续发病情况。
与不吸烟者相比,在怀孕前或怀孕早期继续吸烟的甲状腺功能正常的母亲,血清 fT3(p<0.001)水平更高,fT4(p=0.023)水平更低。与不吸烟者相比,在怀孕中期吸烟与 fT3(p<0.001)浓度升高有关,但 fT4 浓度没有差异。与不吸烟者相比,吸烟母亲的 TG-Ab 发生率较低(2.5%比 4.7%,p<0.001),但 TPO-Ab 的发生率相似。父亲吸烟对母亲孕早期甲状腺激素或抗体浓度无独立影响。在 20 年的随访后,与备孕期间不吸烟者相比,备孕期间吸烟者发生后续甲状腺功能减退症的风险相似。
在甲状腺功能正常的女性中,怀孕期间吸烟与 fT3 水平升高和 fT4 水平降低有关;这可能反映了吸烟引起的甲状腺激素外周代谢改变。吸烟者和不吸烟者之间 TSH 浓度无差异。我们的结果与一般人群不同,一般人群通常表现为吸烟引起的甲状腺刺激。这可能是由于妊娠引起的甲状腺功能变化。吸烟者 fT4 水平下降可能导致妊娠期间甲状腺功能减退症或低甲状腺素血症。尽管甲状腺功能发生了这些变化,但吸烟并未增加女性随后发生甲状腺功能减退症的风险。